Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV)

Advances in Experimental Medicine and Biology

Volumn 577, Issue , 2006, Pages 19-45

  Knowles, Wendy A ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BK VIRUS; GENETICS; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; JC VIRUS; REVIEW; VIROLOGY; VIRUS INFECTION;

BK VIRUS; HUMANS; JC VIRUS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 33745630722     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-32957-9_2     Document Type: Review

References (185)

1. Gardner SD, Field AM, Coleman DV et al. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971; I:1253-1257.
2. Padgett BL, Walker DL, Zu Rhein GM et al. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971; i:1257-1260.
3. Åström KE, Mancall EL, Richardson EP. Progressive multifocal leukoencephalopathy. A hitherto unrecognised complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain 1958; 81:93-111.
4. Cavanagh JB, Greenbaum D, Marshall AHE et al. Cerebral demyelination associated with disorders of the reticuloendothelial system. Lancet 1959; 2:524-529.
5. Richardson EP. Progressive multifocal leukoencephalopathy. New Engl J Med 1961; 265:815-823
6. ZuRhein GM, Chou SM. Particles resembling papova viruses in human cerebral demyelinating disease. Science 1965; 148:1477-1479.
7. Silverman L, Rubinstein LJ. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta neuropathol (Berl) 1965; 5:215-224.
8. Åström KE. Progressive multifocal leukoencephalopathy: The discovery of a neurologic disease. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:1-10.
9. ZuRhein GM. Papova virions in progressive multifocal leukoencephalopathy: A discovery at the interface of neuropathology, virology, and oncology. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:11-23.
10. Walker DL. Progressive multifocal leukoencephalopathy: Cultivation and characterization of the etiologic agent. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:25-43.
11. Knowles WA. Serendipity - the fortuitous discovery of BK virus. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:45-51.
12. Goudsmit J, Wertheim-van Dillen P, van Strien A et al. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J Med Virol 1982; 10:91-99.
13. Monaco MCG, Jensen PN, Hou J et al. Detection of JC virus DNA in human tonsil tissue: Evidence for site of initial viral infection. J Virol 1998; 72:9918-9923.
14. Ling PD, Lednicky JA, Keitel WA et al. The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study. J Infect Dis 2003; 187:1571-1580.
15. Brown P, Tsai T, Gajdusek DC. Seroepidemiology of human papovaviruses. Amer J Epidem 1975; 102:331-340.
16. Padgett BL, Walker DL. New human papovaviruses. Prog Med Virol 1976; 22:1-35.
17. Iwasaki K, Yano K, Yanagisawa Y et al. Incidence of antibody against BK virus among Tokyoites and animals in Tokyo. Ann Rep Tokyo Metr Res Lab 1974; 25:69-72.
18. Seganti L, Mastromarino P, Superti F et al. Comparative study of nonantibody inhibitors present in plasma of different animal species and active towards BK virus, a human papovavirus. Microbiologica 1981; 4:395-402.
19. Padgett BL, Rogers CM, Walker DL. JC virus, a human polyomavirus associated with progressive multifocal leukoencephalopathy: Additional biological characteristics and antigenic relationships. Inf Immun 1977; 15:656-662.
20. Gardner SD. Implication of papovaviruses in human diseases. In: Kurstak E, Kurstak C, eds. Comparative Diagnosis of Viral Diseases. I. Human and Related Viruses. Part A. Chapter 3. New York: Academic Press, 1977:41-84.
21. Taguchi F, Kajioka J, Miyamura T. Prevalence rate and age of acquisition of antibodies against JC virus and BK virus in human sera. Microbiol Immunol 1982; 26:1057-1064.
22. Walker DL, Padgett BL. The epidemiology of human polyomaviruses. In: Sever JL, Madden DL, eds. Polyomaviruses and Human Neurological Disease. Prog Clin Biol Res 105. New York: A.R.Liss, 1983:99-106.
23. Hamilton RS, Gravell M, Major EO. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus. J Clin Microbiol 2000; 38:105-109.
24. Knowles WA, Pipkin P, Andrews N et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71:115-123.
25. Mäntyjärvi RA, Meurman OH, Vihma L et al. A human papovavirus (B.K.), biological properties and seroepidemiology. Ann Clin Res 1973; 5:283-287.
26. Hashida Y, Gaffney PC, Yunis EJ. Acute hemorrhagic cystitis of childhood and papovavirus-like particles. J Pediat 1976; 89:85-87.
27. van der Noordaa J, Wertheim-van Dillen P. Rise in antibodies to human papova virus BK and clinical disease. BMJ 1977; 1:1471.
28. Goudsmit J, Baak ML, Slaterus KW et al. Human papovavirus isolated from urine of a child with acute tonsillitis. BMJ 1981; 283:1363-1364.
29. Mininberg DT, Watson C, Desquitado M. Viral cystitis with transient secondary vesicoureteral reflux. J Urol 1982; 127:983-985.
30. Padgett BL, Walker DL, Desquitado MM et al. BK virus and nonhaemorrhagic cystitis in a child. Lancet 1983; 1:770.
31. Saitoh K, Sugae N, Koike N et al. Diagnosis of childhood BK virus cystitis by electron microscopy and PCR. J Clin Path 1993; 46:773-775.
32. Gardner SD, Knowles WA. Human polyomaviruses. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Principles and Practice of Clinical Virology. 3rd ed. UK: John Wiley, 1995:635-651.
33. Voltz R, Jäger G, Seelos K et al. BK virus encephalitis in an immunocompetent patient. Arch Neurol 1996; 53:101-103.
34. Blake K, Pillay D, Knowles W et al. JC virus associated meningoencephalitis in an immunocompetent girl. Arch Dis Childhood 1992; 67:956-957.
35. Heritage J, Chesters PM, McCance DJ. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J Med Virol 1981; 8:143-150.
36. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147:676-684.
37. Grinnell BW, Padgett BL, Walker DL. Distribution of nonintegrated DNA from JC papovavirus in organs of patients with progressive multifocal leukoencephalopathy. J Infect Dis 1983; 147:669-675.
38. Tornatore C, Berger JR, Houff SA et al. Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy. Ann Neurol 1992; 31:454-462.
39. Doerries K, Vogel E, Günther S et al. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology 1994; 198:59-70.
40. Lednicky JA, Vilchez RA, Keitel WA et al. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17:801-807.
41. Dolei A, Pietropaolo V, Gomas E. et al. Polyomavirus persistence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 2000; 81:1967-1973.
42. Azzi A, De Santis R, Ciappi S et al. Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals. J Neurovirol 1996; 2:411-416.
43. Chatterjee M, Weyardt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol 2000; 60:353-362.
44. Dubois V, Dutronc H, Lafon M-E et al. Latency and reactivation of JC virus in peripheral blood of human immunodeficiency virus type 1-infected patients. J Clin Microbiol 1997; 35:2288-2292.
45. Lafon M-E, Dutronc H, Dubois V et al. JC virus remains latent in peripheral blood B lymphocytes but replicated actively in urine from AIDS patients. J Infect Dis 1998; 177:1502-1505.
46. Gu Z-Y, Li Q, Si Y-L et al. Prevalence of BK virus and JC virus in peripheral blood leucocytes and normal arterial walls in healthy individuals in China. J Med Virol 2003; 70:600-605.
47. Gardner SD. Prevalence in England of antibody to human polyomavirus (B.K.). BMJ 1973; i:77-78.
48. Panà A, Di Arca SU, Castello C et al. Prevalence in the Rome healthy population of antibodies to a human polyoma-virus (BK-strain). Boll Ist Sieroter Milan 1976; 55:18-22.
49. Rziha H-J, Bornkamm GW, zur Hausen H. BK virus. I. Scroepidemiologic studies and serologic response to viral infection. Med Microbiol Immunol 1978; 165:73-81.
50. Portolani M, Marzocchi A, Barbanti-Brodano G et al. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol 1974; 7:543-546.
51. Dei R, Marmo F, Corte D et al. Age-related changes in the prevalence of precipitating antibodies to BK virus in infants and children. J Med Microbiol 1982; 15:285-291.
52. Mäntyjärvi RA, Arstila PP, Meurman OH. Hemagglutination by BK virus, a tentative new member of the papovavirus group. Infect Immun 1972; 6:824-828.
53. Takemoto KK, Mullarkey MF. Human papovavirus, BK strain: Biological studies including antigenic relationship to simian virus 40. J Virol 1973; 12:625-631.
54. Jung M, Krech U, Price PC et al. Evidence of chronic persistent infections with polyomaviruses (BK type) in renal transplant recipients. Arch Virol 1975; 47:39-46.
55. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis 1973; 127:467-470.
56. Shah K, Daniel R, Madden D et al. Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect Immun 1980; 30:29-35.
57. De Stasio A, Orsi N, Panà A et al. The importance of pretreatment of human sera for the titration of hemagglutination-inhibiting antibodies towards BK virus. Ann Sclavo 1979; 21:249-257.
58. De Stasio A, Mastromarino P, Panà A et al. Characterization of a glycoprotein inhibitor present in human serum and active towards BK virus hemagglutination. Microbiologica 1980; 3:293-305.
59. Burguière AM, Fortier B, Bricout F et al. Control of BK virus antibodies in contacts of patients under chronic hemodialysis or after renal transplantation (by an enzyme linked immunosorbent assay). Path Biol 1980; 28:541-544.
60. Iltis JP, Cleghorn CS, Madden DL et al. Detection of antibody to BK virus by enzyme-linked immunosorbent assay compared to hemagglutination inhibition and immunofluorescent antibody staining. In: Sever JL, Madden DL, eds. Polyomaviruses and Human Neurological Disease. Prog Clin Biol Res 105. New York: A.R.Liss, 1983:157-168.
61. Flaegstad T, Traavik T. Detection of BK virus antibodies measured by enzyme-linked immunosorbent assay (ELISA) and two haemagglutination inhibition methods: A comparative study. J Med Virol 1985; 16:351-356.
62. Flaegstad T, Traavik T, Kristiansen B-E. Age-dependent prevalence of BK virus IgG and IgM antibodies measured by enzyme-linked immunosorbent assays (ELISA). J Hyg Camb 1986; 96:523-528.
63. Andrews CA, Shah KV, Daniel RW et al. A serological investigation of BK virus and JC virus infections in recipients of renal allografts. J Infect Dis 1988; 158:176-181.
64. Flaegstad T, Rönne K, Filipe AR et al. Prevalence of anti BK virus antibody in Portugal and Norway. Scand J Infect Dis 1989; 21:145-147.
65. Frye S, Trebst C, Dittmer U et al. Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. J Virol Methods 1997; 63:81-92.
66. Chang D, Liou Z-M, Ou W-C et al. Production of the antigen and the antibody of the JC virus major capsid protein VP1. J Virol Methods 1996; 59:177-187.
67. Weber T, Trebst C, Frye S et al. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J Infect Dis 1997; 176:250-262.
68. Rollison DE, Helzlsouer KJ, Alberg AJ et al. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev 2003; 12:460-463.
69. Viscidi RP, Rollison DEM, Viscidi E et al. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin Diag Lab Immunol 2003; 10:278-285.
70. Carter JJ, Madeleine MM, Wipf GC et al. Lack of serologic evidence for prevalent simian virus 40 infection in humans. J Natl Cancer Inst 2003; 95:1522-1530.
71. Stolt A, Sasnauskas K, Koskela P et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003; 84:1499-1504.
72. Flaegstad T, Traavik T, Christie KE et al. Neutralization test for BK virus: Plaque reduction detected by immunoperoxidase staining. J Med Virol 1986; 19:287-296.
73. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973; 128:784-787.
74. Tavis JE, Frisque RJ, Walker DL et al. Antigenic and transforming properties of the DB strain of the human polyomavirus BK virus. Virology 1990; 178:568-572.
75. Dougherty RM, DiStefano HS. Isolation and characterization of a papovavirus from human urine. Proc Soc Exp Biol Med 1974; 146:481-487.
76. Golubjatnikov et al. cited in Padgett BL, Walker DL. Natural History of Human Polyomavirus Infections. In: Stevens JG, Todaro GJ, Fox CF, eds. Persistent Viruses. ICN-UCLA Symposia on Molecular and Cellular Biology XI. Chapter 54. New York: Academic Press, 1978:751-758.
77. Candeias JAN, Baruzzi RG, Pripas S et al. Prevalence of antibodies to the BK and JC papovaviruses in isolated populations. Rev Saúde públ, S Paulo 1977; 11:510-514.
78. Minor P, Pipkin P, Jarzebek Z et al. Studies of neutralising antibodies to SV40 in human sera. J Med Virol 2003; 70:490-495.
79. Flower AJE, Banatvala JE, Chrystie IL. BK antibody and virus-specific IgM responses in renal transplant recipients, patients vdth malignant disease, and healthy people. BMJ 1977; ii:220-223.
80. Meurman OH, Mäntyjärvi RA, Salmi AA et al. Prevalence of antibodies to a human papova virus (BK virus) in subacute sclerosing panencephalitis and multiple sclerosis patients. Z Neurol 1972; 203:191-194.
81. Corallini A, Barbanti-Brodano G, Portolani M et al. Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia. Infect Immun 1976; 13:1684-1691.
82. Krech U, Jung M, Price PC et al. Virus infections in renal transplant recipients. Z Immun-Forsch 1975; l48:S34l-355.
83. Szücs Gy, Kende M, Új M. Haemagglutination-inhibiting antibodies to B.K. virus in Hungary. Acta microbiol Acad Sci Hung 1979; 26:173-178.
84. Billaudel S, Le Bris JM, Soulillou JP et al. Anticorps inhibant l'hémagglutination du virus BK: brève surveillance de 52 transplantés rénaux et prévalence dans différents groupes d'âge de l'ouest de la France. Ann Virol (Inst. Pasteur) 1981; 132E:337-345.
85. Neel JV, Major EO, Awa AA et al. Hypothesis: "Rogue cell"-type chromosomal damage in lymphocytes is associated with infection with the JC human polyoma virus and has implication for oncogenesis. Proc Natl Acad Sci USA 1996; 93:2690-2695.
86. Taguchi F, Nagaki D, Saito M et al. Transplacental transmission of BK virus in human. Japan J Microbiol 1975; 19:395-398.
87. Major EO, Neel JV. The JC and BK human polyoma viruses appear to be recent introductions to some South American Indian tribes: There is no serological evidence of cross-reactivity with the simian polyoma virus SV40. Proc Natl Acad Sci 1998; 95:15525-15530.
88. Markoulatos P, Spirou N, Ghubril V et al. Données préliminaires sur la présence d'anticorps antivirus BK (groupe papova) dans deux populations différentes de la Grèce. Arch Inst Past Hellén 1981; 27:45-51.
89. Merletti L. Sieroepidemiologia umana del polyoma virus BK in Umbria. Boll Ist Sieroter Milan 1976; 55:573-576.
90. Rziha H-J, Belohradsky BH, Schneider U et al. BK virus: II. Serologic studies in children with congenital disease and patients with malignant tumors and immunodeficiencies. Med Microbiol Immunol 1978; 165:83-92.
91. Brown DWG, Gardner SD, Gibson PE et al. BK virus specific IgM responses in cord sera, young children and healthy adults detected by RIA. Arch Virol 1984; 82:149-160.
92. Daniel R, Shah K, Madden D et al. Serological investigation of the possibility of congenital transmission of papovavirus JC. Inf Immun 1981; 33:319-321.
93. Hogan TF, Borden EC, McBain JA et al. Human polyomavirus infections with JC virus and BK virus in renal transplant patients. Ann Intern Med 1980; 92:373-378.
94. Coleman DV, Wolfendale MR, Daniel RA et al. A prospective study of human polyomavirus infection in pregnancy. J Infect Dis 1980; 142:1-8.
95. Gardner SD, Mackenzie EFD, Smith C et al. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol 1984; 37:578-586.
96. Chang H, Wang M, Tsai RT et al. High incidence of JC viruria in JC-seropositive older individuals. J Neurovirol 2002; 8:447-451.
97. Knowles WA, Gibson PE, Hand JF et al. An M-antibody capture radioimmunoassay (MACRIA) for detection of JC virus-specific IgM. J Virol Methods 1992; 40:95-106
98. Reese JM, Reissig M, Daniel RW et al. Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy. Infect Immun 1975; 11:1375-1381.
99. Hogan TF, Padgett BL, Walker DL et al. Rapid detection and identification of JC virus and BK virus in human urine by using immunofluorescence microscopy. J Clin Microbiol 1980; 11:178-183.
100. Kahan AV, Coleman DV, Koss LG. Activation of human polyomavirus infection- detection by cytologic technics. Amer J Clin Path 1980; 74:326-332.
101. Cobb JJ, Wickenden C, Snell ME et al. Use of hybridot assay to screen for BK and JC polyomaviruses in nonimmunosuppressed patients. J Clin Pathol 1987; 40:777-781.
102. Itoh S, Irie K, Nakamura Y et al. Cytologic and genetic study of polyomavirus-infected or polyomavirus-activated cells in human urine. Arch Path Lab Med 1998; 122:333-337.
103. Marrero M, Pascale F, Alvarez M et al. Dot ELISA for direct detection of BK virus in urine samples. Acta Virol 1990; 34:563-567.
104. Penney JB, Narayan O. Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun 1973; 8:299-300.
105. Albert AE, ZuRhein GM. Application of immune electron microscopy to the study of the antigenic relationships between three new human papovaviruses. Int Arch Allergy 1974; 46:405-416.
106. Gardner SD. The new human papovaviruses: Their nature and significance. In: Waterson AP, ed. Recent Advances in Clinical Virology. No.I. Chapter 6. Edinburgh: Churchill Livingstone, 1977:93-115.
107. Arthur RR, Shah KV, Yolken RH et al. Detection of human papovaviruses BKV and JCV in urines by ELISA. In: Sever JL, Madden DL, eds. Polyomaviruses and Human Neurological Disease. Prog Clin Biol Res 105. New York: AR Liss, 1983:169-176.
108. Arthur RR, Beckmann AM, Li CC et al. Direct detection of the human papovavirus BK in urine of bone marrow transplant recipients: Comparison of DNA hybridization with ELISA. J Med Virol 1985; 16:29-36.
109. Gibson PE, Gardner SD, Porter AA. Detection of human polyomavirus DNA in urine specimens by hybridot assay. Arch Virol 1985; 84:233-240.
110. Kitamura T, Aso Y, Kuniyoshi N et al. High incidence of urinary JC virus excretion in nonimmunosuppressed older patients. J Infect Dis 1990; 161:1128-1133.
111. Kitamura T, Yogo Y, Kunitake T et al. Effect of immunosuppression on the urinary excretion of BK and JC polyomaviruses in renal allograft recipients. Int J Urol 1994; 1:28-32.
112. Arthur RR, Shah KV. Occurrence and significance of papovaviruses BK and JC in the urine. Prog Med Virol 1989; 36:42-61.
113. Arthur RR, Dagostin S, Shah KV. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J Clin Microbiol. 1989; 27:1174-1179.
114. Marshall WF, Telenti A, Proper J et al. Survey of urine from transplant recipients for polyomaviruses JC and BK using the polymerase chain reaction. Mol Cell Probes 1991; 5:125-128.
115. Markowitz R-B, Thompson HC, Mueller JF et al. Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. J Infect Dis 1993; 167:13-20.
116. Agostini HT, Ryschkewitsch CF, Stoner GL Genotype profile of human polyomavirus JC excreted in urine of immunocompetent individuals. J Clin Microbiol 1996; 34:159-164.
117. Stoner GL, Agostini HT, Ryschkewitsch CF et al. Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients. Mult Scler 1996; 1:193-199
118. Agostini HT, Yanagihara R, Davis V et al. Asian genotypes of JC virus in Native Americans and in a Pacific Island population: Markers of viral evolution and human migration. Proc Nat Acad Sci USA 1997; 94:14542-14546.
119. Shah KV, Daniel RW, Strickler HD et al. Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus. J Infect Dis 1997; 176:1618-1621.
120. Yogo Y, Iida T, Taguchi F et al. Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms. J Clin Microbiol 1991; 29:2130-2138.
121. Jin L, Gibson PE, Booth JC et al. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J Med Virol 1993; 41:11-17.
122. Bogdanovic G, Brytting M, Cinque P et al. Nested PCR for detection of BK virus and JC virus DNA. Clin Diagn Virol 1994; 2:127-136.
123. Sundsfjord A, Flaegstad T, Flø R et al. BK and JC viruses in human immunodeficiency virus type 1-infected persons: Prevalence, excretion, viremia, and viral regulatory regions. J Infect Dis 1994; 169:485-490.
124. Gibson PE. Detection of human polyomaviruses by PCR. In: Clewley JP, ed. The Polymerase Chain Reaction (PCR) for Human Viral Diagnosis. Chapter 14. Florida: CRC Press, 1995:14:197-203.
125. Jin L, Pietropaolo V, Booth JC et al. Prevalence and distribution of BK virus subtypes in healthy people and immuncompromised patients detected by PCR-restriction enzyme analysis. Clin Diag Virol 1995; 3:285-295.
126. Di Taranto C, Pietropaolo V, Orsi GB et al. Detection of BK polyomavirus genotypes in healthy and HIV-positive children. Europ J Epidem 1997; 13:653-657.
127. Degener AM, Pietropaolo V, Di Taranto C et al. Detection of JC and BK viral genome in specimens of HIV-1 infected subjects. Microbiologica 1997; 20:115-122.
128. Sundsfjord A, Osei A, Rosenqvist H et al. BK and JC viruses in patients with systemic lupus erythematosus: Prevalent and persistent BK viruria, sequence stability of the viral regulatory regions, and nondetectable viremia. J Infect Dis 1999; 180:1-9.
129. Azzi A, Cesaro S, Laszlo D et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14:79-86.
130. Agostini HT, Deckhut A, Jobes DV et al. Genotypes of JC virus in east, central and southeast Europe. J Gen Virol 2001; 82:1221-1231.
131. Pagani E, Delbue S, Mancuso R et al. Molecular analysis of JC virus genotypes circulating among the Italian healthy population. J Neurovirol 2003; 9:559-566.
132. Kitamura T, Kunitake T, Guo J et al. Transmission of the human polyomavirus JC virus occurs both within the family and outside the family. J Clin Microbiol 1994; 32:2359-2363
133. Tsai R-T, Wang M, Ou W-C et al. Incidence of JC viruria is higher than that of BK viruria in Taiwan. J Med Virol 1997; 52:253-257.
134. Chang D, Sugimoto C, Wang M et al. JC virus genotypes in a Taiwan aboriginal tribe (Bunun): Implication for its population history. Arch Virol 1999; 144:1081-1090.
135. Ryschkewitsch CF, Friedlaender JS, Mgone CS et al. Human polyomavirus JC variants in Papua New Guinea and Guam reflect ancient population settlement and viral evolution. Microbes and Infection 2000; 2:987-996.
136. Saruwatari L, Sugimoto C, Kitamura T et al. Asian domains of four major genotypes of JC virus, Af2, B1-b, CY and SC. Arch Virol 2002; 147:1-10.
137. Chima SC, Ryschkewitsch CF, Stoner GL. Molecular epidemiology of human polyomavirus JC in the Biaka Pygmies and Bantu of Central Africa. Mem Inst Oswaldo Cruz, Rio de Janeiro 1998; 93:615-623.
138. Arthur RR, Shah KV, Charache P et al. BK and JC virus infections in recipients of bone marrow transplants. J Infect Dis 1988; 158:563-569.
139. Chang D, Tsai R-T, Wang M et al. Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. J Med Virol 1996; 48:204-209.
140. Bendiksen S, Rekvig OP, Van Ghelue M et al. VP1 DNA sequences of JC and BK viruses detected in urine of systemic lupus erythematosus patients reveal no differences from strains expressed in normal individuals. J Gen Virol 2000; 81:2625-2633.
141. Knowles WA, Pillay D, Johnson MA et al. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999; 59:474-479.
142. Markowitz R-B, Eaton BA, Kubik MF et al. BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. J Virol 1991; 65:4515-4519.
143. Chang D, Wang M, Ou W-C et al. Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. J Med Virol 1996; 48:95-101.
144. Jin L. Rapid genomic typing of BK virus directly from clinical specimens. Mol Cell Probes 1993; 7:331-334.
145. Sundsfjord A, Spein A-R, Lucht E et al. Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients. J Clin Microbiol 1994; 32:1390-1394.
146. Agostini HT, Jobes DV, Stoner GL. Molecular evolution and epidemiology of JC virus. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:491-526.
147. Arthur RR. Detection of JC and BK viruses in pathological specimens by polymerase chain reaction. In: Becker Y, Daria G, eds. Frontiers of Virology I Diagnosis of human viruses by polymerase chain reaction technology. Chapter 17. Springer-Verlag, 1992:219-227.
148. Kitamura T, Sugimoto C, Kato A et al. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol 1997; 35:1255-1257.
149. Agostini HT, Ryschkewitsch CF, Baumhefner RW et al. Influence of JC virus coding region genotype on risk of multiple sclerosis and progressive multifocal leukoencephalopathy. J Neurovirol 2000; 6:S101-108.
150. Bofill-Mas S, Pina S, Girones R. Documenting the epidemiologic patterns of polyomaviruses in human populations by studying their presence in urban sewage. Appl Environ Microbiol 2000; 66:238-245.
151. Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P et al. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA. J Virol 2001; 75:10290-10299.
152. Ault GS, Stoner GL. Human polyomavirus JC promoter/enhancer rearrangement patterns from progressive multifocal leukoencephalopathy brain arc unique derivatives of a single archetypal structure. J Gen Virol 1993; 74:1499-1507.
153. Iida T, Kitamura T, Guo J et al. Origin of JC polyomavirus variants associated with progressive multifocal leukoencephalopathy. Proc Nat Acad Sci 1993; 90:5062-5065.
154. Agostini HT, Ryschkewitsch CF, Stoner GL. Rearrangements of archetypal regulatory regions in JC virus genomes from urine. Res Virol 1998; 149:163-170.
155. Monini P, Rotola A, de Lellis L et al. Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer 1996; 66:717-722.
156. McCance DJ, Mims CA. Transplacental transmission of polyoma virus in mice. Infect Immun 1977; 18:196-202.
157. McCance DJ, Mims CA. Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy. Infect Immun 1979; 25:998-1002.
158. Borgatti M, Costanzo F, Portolani M et al. Evidence for reactivation of persistent infection during pregnancy and lack of congenital transmission of BK virus, a human papovavirus. Microbiologica 1979; 2:173-178.
159. Gibson PE, Field AM, Gardner SD et al. Occurrence of IgM antibodies against BK and JC polyomaviruses during pregnancy. J Clin Path 1981; 34:674-679.
160. Pietropaolo V, Di Taranto C, Degener AM et al. Transplacental transmission of human polyomavirus BK. J Med Virol 1998; 56:372-376.
161. Penta M, Lukic A, Conte MP et al. Infectious agents in tissues from spontaneous abortions in the first trimester of pregnancy. Microbiologica 2003; 26:329-337.
162. Kunitake T, Kitamura T, Guo J et al. Parent-to-child transmission is relatively common in the spread of the human polyomavirus JC virus. J Clin Microbiol 1995; 33:1448-1451.
163. Agostini HT, Ryschkewitsch CF, Stoner GL. JC virus Type 1 has multiple subtypes: Three new complete genomes. J Gen Virol 1998; 79: 801-805.
164. Suzuki H, Zheng H-Y, Takasaka T.et al. Asian genotypes of JC virus in Japanese-Americans suggest familial transmission. J Virol 2002; 76:10074-10078.
165. Kato A, Kitamura T, Sugimoto C et al. Lack of evidence for the transmission of JC polyomavirus between human populations. Arch Virol 1997; 142:875-882.
166. Agostini HT, Ryschkewitsch CF, Singer EJ et al. Co-infection with two JC virus genotypes in brain, cerebrospinal fluid or urinary tract detected by direct cycle sequencing of PCR products. J Neurovirol 1996; 2:259-267.
167. Yogo Y, Sugimoto C. The archetype concept and regulatory region rearrangement. In: Khalili K, Stoner GL, eds. Human Polyomaviruses: Molecular and Clinical Perspectives. New York: Wiley-Liss, 2001:127-148.
168. Kato K, Guo J, Taguchi F et al. Phylogenetic comparison between archetypal and disease-associated JC virus isolates in Japan. Jpn J Med Sci Biol 1994; 47:167-178.
169. Agostini HT, Ryschkewitsch CF, Singer EJ et al. JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: Two independent aspects of virus variation. J Gen Virol 1997; 78:659-664.
170. Knowles WA, Gibson PE, Gardner SD. Serological typing scheme for BK-like isolates of human polyomavirus. J Med Virol 1989; 28:118-123.
171. Tavis JE, Walker DL, Gardner SD et al. Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus. J Virol 1989; 63:901-911.
172. Jin L, Gibson PE, Knowles WA et al. BK virus antigenic variants: Sequence analysis within the capsid VP1 epitope. J Med Virol 1993; 39:50-56.
173. Agostini HT, Brubaker GR, Shao J et al. BK virus and a new type of JC virus excreted by HIV-1 positive patients in rural Tanzania. Arch Virol 1995; 140:1919-1934.
174. Baksh FK, Finkelstein SD, Swalsky PA et al. Molecular genotyping of BK and JC viruses in human polyomavirus-associated interstitial nephritis after renal transplantation. Amer J Kid Dis 2001; 38:354-365.
175. Priftakis P, Bogdanovic G, Kalantari M et al. Overrepresentation of point mutations in the Spl site of the noncoding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis. J Clin Virol 2001; 21:1-7.
176. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002; 73:1090-1094.
177. Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. In: Sever JL, Madden DL, eds. Polyomaviruses and Human Neurological Disease. Prog Clin Biol Res 105. New York: A R Liss, 1983:107-117.
178. Ault GS, Stoner GL. Two major types of JC virus defined in progressive multifocal leukoencephalopathy brain by early and late coding region DNA sequences. J Gen Virol 1992; 73:2669-2678.
179. Sala M, Vartanian J-P, Kousignian P et al. Progressive multifocal leukoencephalopathy in human immunodeficiency virus type 1-infected patients: Absence of correlation between JC virus neurovirulence and polymorphisms in the transcriptional control region and the major capsid protein loci. J Gen Virol 2001; 82:899-907.
180. Guo J, Sugimoto C, Kitamura T et al. Four geographically distinct genotypes of JC virus are prevalent in China and Mongolia: Implication for the racial composition of modern China. J Gen Virol 1998; 79:2499-2505.
181. Fernandez-Cobo M, Jobes DV, Yanagihara R et al. Reconstructing population history using JC virus: Amerinds, Spanish, and Africans in the ancestry of modern Puerto Ricans. Hum Biol 2001; 73:385-402.
182. Fernandez-Cobo M, Agostini HT, Britez G et al. Strains of JC virus in Amerind-speakers of North America (Salish) and South America (Guarani), Na-Dene-speakers of New Mexico (Navajo), and modern Japanese suggest links through an ancestral Asian population. Amer J Phys Anthropol 2002; 118:154-168.
183. Sugimoto C, Hasegawa M, Zheng HY et al. JC virus strains indigenous to northeastern Siberians and Canadian Inuits are unique but evolutionally related to those distributed throughout Europe and Mediterranean areas. J Mol Evol 2002; 55:322-335.
184. Yanagihara R, Nerurkar VR, Scheirich I et al. JC virus genotypes in the western Pacific suggest Asian mainland relationships and virus association with early population movements. Hum Biol 2002; 74:473-488.
185. Ikegaya H, Iwase H, Sugimoto C et al. JC virus genotyping offers a new means of tracing the origins of unidentified cadavers. Int J Legal Med 2002; 116:242-245.